Clinical Trial Update: The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effects of ropinirole on mood or mild depression in patients with moderate to severe restless legs syndrome; the study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• REQUIP (ropinirole hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome, Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) | Phase 3 | Status: COMPLETED | Results posted: 2009-09-16